This 2020 position statement by EMAS and IGCS offers comprehensive guidelines on the management of menopausal symptoms and osteoporosis in women who have undergone treatment for gynecological cancers. It advocates individualized care based on cancer type, treatment history, and hormone receptor status. For women with early-stage, low-grade endometrial cancer, menopausal